CDC Ethiopia Faith Based HIV TB Grant Eligibility Guide
Updated 5 official sources
Quick Answer: CDC-RFA-JG-26-0136, a 2026 forecast to fund faith-based organizations for HIV, TB, and cervical cancer services in Ethiopia, has been withdrawn.
Full answer and how we checked it
Grants.gov no longer has a record of it, and CDC hasn't posted a replacement. The forecast had listed about $5,000,000 in year-1 funding and 2 expected awards. Use this guide only as a fit screen in case CDC reissues a similar notice.
Who this is for: Faith-based organizations, public health nonprofits, universities, and implementation partners deciding whether they can credibly deliver CDC/PEPFAR-aligned HIV and TB services in Ethiopia.
Data note: This guide uses the former Simpler.Grants.gov forecast for CDC-RFA-JG-26-0136 (as read on June 2, 2026), CDC's Ethiopia HIV and TB overview, the CDC Ethiopia HIV and TB program record, and USAspending.gov award data. Grantsights rechecked the forecast's status on Grants.gov and Simpler.Grants.gov on October 10, 2026 and found it withdrawn.
In this guide
- October 2026 Status Check: Forecast Withdrawn
- CDC Ethiopia Faith Based HIV TB Grant Eligibility: 5 Fit Tests
- Funding, Timing, and Service Scope
- CDC Ethiopia Route vs Ryan White, Domestic CDC, and Foundation Funding
- What CDC Doesn't Tell You
- 5 Real-World CDC Ethiopia Scenarios
- 7 Lead Application Checklist Items to Run First
- 7 Lead-or-Partner Questions Before Writing
- 30-Day Partner Diligence Plan
- 5 Evidence Artifacts To Collect Before Drafting
- Grantsights Trust Check: Apply or Skip This Path
- Sources
Quick Facts
- Agency
- HHS
- Funding
- $0K - $0K
- Deadline
- Check official source
- Status
- Closed
Assistance Listing 93.067: all awards
Source: USASpending.gov FY2024These figures cover all Centers for Disease Control-GHC awards under Assistance Listing 93.067, of every award type. They are not figures for the award this guide describes, and one award of that kind can be far smaller.
- Total Awards (FY2024, whole listing)
- 431
- Avg Award (whole listing)
- $25,317,898
- Median Award (whole listing)
- $11,671,480
- Total Funding (FY2024, whole listing)
- $1.7B
- YoY Funding Trend
- +3.1%
Data last verified: May 18, 2026
This CDC forecast was not a generic faith-based grant, and it's no longer listed. According to the Simpler.Grants.gov forecast before it was withdrawn, the opportunity would have engaged faith-based organizations to support HIV, TB, and cervical cancer services in Ethiopia, including HIV testing, prevention of vertical transmission, adult and pediatric HIV care and treatment, and service links for people who face barriers to conventional health facility services.
According to PEPFAR (opens in a new tab), country programs use local partners and health-system delivery to sustain HIV prevention, testing, care, and treatment. That makes CDC Ethiopia applicant fit a delivery question, not only an eligibility question.
Use this guide with the CDC Ethiopia HIV and TB program record, then compare broader HIV funding options in HIV AIDS grants, Ryan White HIV grants, and Ryan White program guide. Health nonprofits often overread broad eligibility. For CDC global HIV work, delivery proof matters more than category eligibility.
Where official sources stop: CDC and PEPFAR sources describe Ethiopia HIV and TB priorities, but they do not grade whether a faith-based applicant can deliver the full service stack. Our screen looks for in-country operating proof, faith-community trust, HIV and TB service links, cervical-cancer support capacity, and CDC cooperative-agreement readiness. That changes the next action: broad eligibility is not enough unless the applicant can show delivery systems and partners already working in Ethiopia.
October 2026 Status Check: Forecast Withdrawn
On October 10, 2026, the Grants.gov record for this forecast (opportunity 360707) returned no record, the Simpler.Grants.gov listing returned "Page Not Found," and a Simpler.Grants.gov search for CDC-RFA-JG-26-0136 across forecasted, open, closed, and archived notices returned nothing. CDC posted other FY2026 global HIV and TB notices for other countries, but no Ethiopia faith-based notice. Treat the forecast as withdrawn.
For the record, when Grantsights read it on June 2, 2026, Simpler.Grants.gov's forecast listing, last updated May 13, 2026, estimated a June 12, 2026 application due date and a September 30, 2026 award date for CDC-RFA-JG-26-0136, with 2 expected awards, no cost share, cooperative agreement as the funding instrument, and about $5,000,000 in year-1 funding subject to funds being available. None of that happened: no notice was posted before the forecast was removed.
| Official source | What it said or says | Grantsights action |
|---|---|---|
| Simpler.Grants.gov forecast (withdrawn) | Faith-based HIV, TB, and cervical-cancer service support in Ethiopia | Don't build a budget or partner agreements around it unless CDC reissues it |
| CDC Ethiopia overview | CDC works with Ethiopia partners on HIV, TB, lab, data, and service delivery through PEPFAR support | Require Ethiopia delivery proof and health-system links |
| CDC Global HIV and TB | CDC's global HIV and TB work is tied to PEPFAR-supported countries | Treat this as CDC/PEPFAR operating work, not a general faith grant |
| PEPFAR | Country programs rely on local delivery partners and health-system results | Ask for partner roles, data flow, and service handoff proof before writing |
If CDC reissues it: The withdrawn forecast said who could apply, but broad applicant categories are not the same as readiness. Grantsights adds the delivery screen: a faith-based applicant needs Ethiopia operating proof, faith-community reach, HIV and TB service links, cervical-cancer support capacity, and CDC cooperative-agreement readiness before it should lead.
CDC Ethiopia Faith Based HIV TB Grant Eligibility: 5 Fit Tests
5 fit tests should happen before a team prepares partners for any reissued notice. The withdrawn listing showed broad applicant categories, including unrestricted, governments, nonprofits, businesses, and education organizations. But broad eligibility does not mean broad competitiveness.
| Fit test | Strong signal | Red flag |
|---|---|---|
| Ethiopia presence | Existing delivery relationships in Ethiopia | No in-country operating model |
| Faith-community reach | Trusted ties with churches, mosques, or faith networks | Generic community outreach claim |
| HIV and TB delivery | Staff can support testing, treatment links, TB care, and retention | Only awareness programming |
| Health-system link | Model integrates with routine health-care delivery | Parallel service model |
| CDC/PEPFAR readiness | Data, compliance, and cooperative-agreement capacity are ready | New federal systems |
The strongest applicants will not simply say they are faith-based. They will show how faith networks reach people at high risk, undiagnosed people living with HIV, people at risk of treatment interruption, pregnant and breastfeeding women, and people facing barriers to facility-based care.
Funding, Timing, and Service Scope
2 expected awards meant the pool would have been selective even with broad eligibility. The withdrawn Simpler.Grants.gov listing said CDC anticipated about $5,000,000 in approximate total fiscal-year funding for year 1, subject to the availability of funds. It also listed an estimated application due date of June 12, 2026 and an estimated award date of September 30, 2026, with cooperative agreement as the funding instrument. The forecast has since been withdrawn, so these numbers describe what CDC once planned, not money you can apply for.
| Former listing signal | Practical meaning if reissued |
|---|---|
| $5,000,000 year-1 funding | Serious delivery capacity is expected |
| 2 expected awards | Partner quality and track record matter |
| Cooperative agreement | CDC involvement should be expected |
| Global AIDS assistance listing | PEPFAR-aligned performance and reporting matter |
| Withdrawn forecast | Nothing to apply for until CDC posts a new notice |
According to the CDC Ethiopia HIV and TB overview, CDC's global HIV and TB division works with countries supported by PEPFAR to end HIV and TB as public health threats. According to USAspending.gov (opens in a new tab) data, Global AIDS assistance listing 93.067 had about $1.69B in FY2024 obligations.
CDC Ethiopia Route vs Ryan White, Domestic CDC, and Foundation Funding
4 nearby funding paths should not be confused. Ryan White is domestic HIV care. Domestic CDC prevention grants support U.S. jurisdictions and community organizations. International foundation funding may support narrower faith or community-health work. This withdrawn CDC Ethiopia forecast was global, cooperative-agreement, and delivery-focused.
| Route | Better first read when... | Why |
|---|---|---|
| CDC Ethiopia HIV/TB FBO grant | Ethiopia faith-community delivery is central | Program intent matches |
| Ryan White | U.S. HIV care and treatment is the focus | Domestic HRSA program |
| Domestic CDC HIV prevention | U.S. testing, prevention, or surveillance | Geography differs |
| Foundation global health | Smaller pilot or faith-network support | Lower federal compliance burden |
For domestic HIV funding, use Ryan White HIV grants. For the full federal HIV map, use HIV AIDS grants. For the program record, see the CDC Ethiopia HIV and TB program record.
What CDC Doesn't Tell You
CDC doesn't announce when a forecast is quietly withdrawn, which is the first thing official pages won't tell you: check the record again before you spend writing time. If a similar notice returns, the hidden test is delivery realism. CDC gives the service categories. It does not tell each applicant whether the faith-network model is trusted, measurable, and aligned with Ethiopia's routine health-care delivery system.
First, according to the CDC Ethiopia overview, the work sits inside a partner and health-system model, so broad eligibility does not equal readiness. A U.S. nonprofit may be eligible, but without Ethiopia operating partners, data capacity, and PEPFAR reporting discipline, the application will read thin.
Second, CDC does not solve faith-network trust. The withdrawn listing was about using faith communities to reach people who may face barriers to conventional services. That requires real relationships, not one memorandum of understanding signed near the deadline.
Third, CDC does not tell you how to prove cost efficiency. The withdrawn listing expected cost-efficient models integrated with routine health-care delivery. The proposal should explain unit costs, referral paths, staffing, and how it avoids duplicating facility services.
Fourth, CDC does not pair listing facts with award data. Grantsights analysis of USAspending data shows about $1.69B in FY2024 obligations in the connected Global AIDS family, but this forecast listed only 2 expected awards before it was withdrawn.
The common mistake is writing a values-based faith proposal instead of a delivery proposal. That is a red flag. The faith component should explain reach, trust, uptake, and retention, not just mission alignment.
5 Real-World CDC Ethiopia Scenarios
5 hypothetical scenarios show which teams should lean in if CDC reissues a similar notice. For example, an Ethiopia-based organization with clinic links, faith-network partners, HIV testing data, and TB referral systems could be a strong contender. A U.S. church network with no Ethiopia delivery partner should probably wait or join as a subpartner.
| Scenario | Better route | Why |
|---|---|---|
| Ethiopia-based FBO health network | CDC Ethiopia grant | Delivery and trust are present |
| U.S. nonprofit with proven Ethiopia partner | Lead or subpartner | Partnership can fill gaps |
| Domestic HIV clinic | Ryan White or domestic CDC | Geography and program differ |
| Faith group with no health data systems | Foundation pilot first | Federal readiness is weak |
| University with implementation research capacity | Partner role possible | Delivery partner still needed |
A U.S. nonprofit might have PEPFAR experience and an Ethiopian faith-health partner with service sites. That can be credible. A small congregation might have mission trips but no HIV care, TB referral, or reporting system. That second case is not ready for a CDC cooperative agreement.
7 Lead Application Checklist Items to Run First
7 checks should be finished before treating any reissued notice as a lead application.
- Confirm Ethiopia delivery partners and roles.
- Map faith-community reach to the target populations named in the notice.
- Show HIV testing, prevention, treatment, TB, and cervical-cancer service links.
- Explain integration with routine health-care delivery.
- Build a CDC/PEPFAR reporting and quality plan.
- Price the year-1 model against the funding level in the new notice (the withdrawn forecast listed $5,000,000).
- Decide whether the organization should lead, co-lead, or subpartner.
According to Simpler.Grants.gov, the forecast was last updated May 13, 2026, before it was withdrawn. According to CDC, its global HIV and TB work is tied to PEPFAR-supported countries. According to USAspending.gov, the connected Global AIDS family is large, but this kind of notice rewards delivery credibility over broad eligibility.
Also ask for a written role map before anyone drafts: who owns faith-community outreach, who owns clinical referral, who owns TB linkage, who owns data reporting, and who owns cooperative-agreement communication with CDC. If the answer is one general partner for everything, the application is probably not ready. If the answer names an Ethiopia delivery lead, a data owner, a health-system liaison, and a compliance lead, the team can make a stronger case.
7 Lead-or-Partner Questions Before Writing
7 questions decide whether an organization should lead, co-lead, subpartner, or skip. The first question is geography. Does the organization have staff, partners, licenses, or operating history in Ethiopia? A good U.S. grant team without Ethiopia delivery capacity should not automatically lead.
The second question is faith-network depth. The withdrawn listing wasn't asking for generic outreach. It asked for work through faith communities that can reach people at high risk, undiagnosed people living with HIV, people at risk of treatment interruption, pregnant and breastfeeding women, and people facing barriers to standard facility services.
The third question is service capability. According to the withdrawn Simpler.Grants.gov forecast, the named services included HIV testing, prevention, adult and pediatric care and treatment, TB service support, and cervical-cancer service support. If the organization only provides education, it needs clinical and public health partners.
The fourth question is data. CDC cooperative agreements usually demand reporting discipline. The applicant should know how it will track testing, linkage, retention, TB referral, treatment interruption, and service handoffs without exposing patient privacy.
The fifth question is integration with routine health-care delivery. The withdrawn listing expected models integrated with the routine health-care delivery system. That means the faith network should connect people to care, not replace the care system with a parallel model.
The sixth question is cost. The withdrawn forecast's $5,000,000 in year-1 funding across 2 expected awards suggested CDC expected serious delivery. The proposal should show unit costs, staffing, referral assumptions, and why the model is cost-efficient.
The seventh question is role. A U.S. nonprofit might be the right compliance or evaluation partner. An Ethiopia-based FBO network might be the right delivery lead. A university might be the right implementation research partner. The best team may not put the loudest grant writer in the lead role.
An Ethiopia-based faith health network with clinic ties and HIV data could make a direct case. A U.S. public health nonprofit with PEPFAR experience but no Ethiopia field staff may be better as a co-lead. A small faith group with only mission-trip experience should build a local partnership before chasing any future notice.
According to the CDC Global HIV and TB division, its country work is tied to PEPFAR-supported programs. That matters because proposals should read like delivery systems, not short-term outreach projects.
30-Day Partner Diligence Plan
30 days should be enough to decide whether the organization should lead, partner, or skip. Days 1 through 5 should verify Ethiopia operating history, legal status, faith-community relationships, and whether the proposed service geography aligns with any new CDC notice. A lead applicant without those facts should slow down before it builds a budget.
Days 6 through 12 should map the service chain. The team should write down how a person moves from faith-community contact to HIV testing, linkage to care, TB screening or referral, cervical-cancer service support, and retention follow-up. If the pathway depends on an unnamed clinic or informal volunteer network, the proposal is not ready.
Days 13 through 20 should test data and privacy. CDC/PEPFAR-style work needs more than activity counts. The team should define what it can track, who enters data, who reviews data quality, and how private health information stays protected when faith-community partners are involved.
Days 21 through 30 should decide role and budget. A U.S. nonprofit may be strongest as compliance or evaluation support. An Ethiopia-based FBO network may be strongest as delivery lead. A university may be strongest on implementation research. The final decision should match role to proof, not to organizational confidence.
5 Evidence Artifacts To Collect Before Drafting
5 evidence artifacts should be in the working folder before the team writes the narrative. First, collect partner evidence: signed roles, existing service locations, faith-community reach, and health-system referral relationships. Second, collect service evidence: HIV testing history, treatment-linkage workflows, TB referral pathways, cervical-cancer service links, and retention support.
Third, collect data evidence. The applicant should be able to show how it currently tracks clients, referrals, follow-up, and quality checks. Fourth, collect compliance evidence. A CDC cooperative agreement can require strong financial controls, subrecipient monitoring, and reporting discipline. Fifth, collect cost evidence. Any new notice's year-1 funding level should be translated into staffing, supervision, transport, referral, data, and partner costs.
If those 5 artifacts are missing, the next step is not a full application. It is partner diligence. That is the difference between a credible Ethiopia delivery proposal and a hopeful faith-based concept.
Grantsights Trust Check: Apply or Skip This Path
Use this page as a decision screen before your team spends writing time. Apply the guidance when the applicant type, deadline, budget size, required evidence, and official submission path all match the source record. Skip or pause when the fit is only thematic, the applicant cannot document eligibility, the deadline leaves no time for review, or the official source points to a different route.
| Decision point | Apply if | Skip or pause if |
|---|---|---|
| Applicant fit | The organization type is named or clearly allowed in the official source | Eligibility is inferred from mission fit rather than stated rules |
| Evidence | The team can document need, partners, budget basis, and past work | The page is being used as a generic idea list without proof |
| Timing | Registrations, roles, attachments, and internal approvals can be ready before the deadline | The team would be rushing portal setup or budget approval |
| Next step | The official source and Grantsights analysis point to the same route | A nearby program or smaller planning step would be safer |
Sources
- Simpler.Grants.gov search for CDC-RFA-JG-26-0136 (forecast withdrawn; no results as of October 10, 2026): simpler.grants.gov (opens in a new tab)
- CDC Ethiopia HIV and TB overview: cdc.gov (opens in a new tab)
- CDC Global HIV and TB: cdc.gov (opens in a new tab)
- PEPFAR: state.gov (opens in a new tab)
- Grantsights CDC Ethiopia HIV and TB program page: Engaging faith-based organizations to sustain lifesaving HIV and TB services in Ethiopia
Largest awards active in FY2024
One row per recipient, its largest award | 431 Assistance Listing records | Avg: $25.3M
World Health Organization
Medical Access Uganda Limited
Use the visible recipient rows as free source context
This program has no reviewed paid report today.
No reviewed paid report is currently offered for this program. The visible source rows remain free.
Next steps
Where to go next
These next pages help you move from research into a specific grant choice.
Open CDC Ethiopia record
Check CDC-RFA-JG-26-0136 forecast status, June 12 2026 due date, 2 expected awards, $5M year-1 signal, and cooperative-agreement fit.
Compare HIV grants
Separate global CDC and PEPFAR-aligned delivery from domestic HRSA, Ryan White, and foundation routes.
Domestic HIV contrast
Use when the applicant's project is U.S. HIV care rather than Ethiopia HIV, TB, and cervical-cancer service delivery.
Compare global CDC route
Review country delivery proof, partner roles, reporting readiness, and lead-versus-partner decisions.
Search current grants
Use when the forecast changes status or a nearby health route becomes the better fit.
Frequently Asked Questions
What is the CDC Ethiopia faith-based HIV and TB grant?
CDC-RFA-JG-26-0136 was a forecasted CDC cooperative agreement to engage faith-based organizations in HIV, TB, and cervical cancer service delivery in Ethiopia. The forecast has been withdrawn: as of October 10, 2026, Grants.gov returns no record for it and a Simpler.Grants.gov search finds no forecasted, open, closed, or archived notice under that number.
How much funding did the forecast list?
Before it was withdrawn, the Simpler.Grants.gov forecast listed about $5,000,000 in total year-1 funding, subject to funds being available. No funding is available now because no notice was posted.
How many awards did it expect?
The withdrawn forecast showed 2 expected awards. CDC hasn't posted a replacement Ethiopia faith-based HIV and TB notice.
What services did the withdrawn forecast name?
The withdrawn forecast named HIV testing, HIV prevention including vertical transmission, adult and pediatric HIV care and treatment, TB services, and cervical cancer service support.
Who should skip this grant?
Skip it if the organization lacks Ethiopia delivery capacity, faith-community relationships, CDC/PEPFAR compliance capacity, or a model tied to health-care delivery systems.
Last updated October 10, 2026. Corrected October 10, 2026: what changed. Published by Grantsights from public sources. See our editorial policy, how we build and check guides, corrections and how we make money.
Related Guides
CDC India HIV TB Grant Eligibility
CDC-RFA-JG-26-0142 closed September 16, 2026, with 2 expected awards. India HIV TB delivery fit, NACO, CTD and NTEP alignment, and partner roles.
CDC Public Health Grants Guide 2026
CDC obligated $4.4 billion in grants in FY2024. Learn how immunization, HIV prevention, chronic disease, PHEP, ELC, and environmental health grants work.
Grants for HIV AIDS 2026: Ryan White, HOPWA, CDC
Ryan White got $2.571B in FY2026 and HOPWA sent $476.1M to 117 grantees. Grants for HIV/AIDS programs, plus what HIV patients can get (no cash grants).
CDC Grants and Cooperative Agreements: Funding Guide 2026
Learn how CDC grants and cooperative agreements differ, how eligibility and substantial involvement work, and where to find current funding notices.
CDC National Partners Cooperative Agreement Guide
CDC National Partners guide: 48 recipients, $176M first-year funding, 5-year cycle, bad-fit signals, and better routes for local applicants.
CDC Recent Awards: FY2026 Grants by Program
CDC signed 530 new grant records worth $338.2 million in FY2026, down from $1.61 billion. See Drug-Free Communities, block grant and partner winners.